Is Novavax Turning Around? A Technical Analysis
February 01, 2022 at 09:39 AM EST
Novavax, Inc. shares are trading higher Monday after the company submitted a request to the U.S Food and Drug Administration for Emergency Use Authorization of its COVID-19 vaccine, NVX-CoV2373.
